Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma

Urology

Volumn 46, Issue 2, 1995, Pages 200-204

  El Galley, R E S ^a   Petros, J A ^a   Sanders, W H ^a   Keane, T E ^a   Galloway, N T M ^a   Cooner, W H ^a   Graham Jr , Sam D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ECHOGRAPHY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; BIOPSY; COMPARATIVE STUDY; HUMAN; MALE; MASS SCREENING; MIDDLE AGE; PHYSICAL EXAMINATION; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERENCE VALUES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0028864739     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80194-0     Document Type: Article

References (19)

1. Cancer statistics, 1994
2. Early detection of prostate cancer
3. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer:results of a multicenter clinical trial of 6,630 men
4. Prostate-specific antigen:concepts for staging prostate cancer and monitoring response to therapy
5. Prostate specific antigen, digital rectal examination, and transrectal ultrasonography: their roles in diagnosing early prostate cancer
6. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
7. Clinical significance of prostate-specific antigen. [Norwegen]
8. Efficient pathway for early detection of prostate cancer concluded from a 5-year prospective study
9. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer
10. The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma
11. PSA density (PSAD) . Role in patient evaluation and management
12. Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate
13. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
14. Screening for prostatic carcinoma with prostate specific antigen:results of the second year
15. Influence of patient age on the serum PSA concentration. An important clinical observation
16. Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer
17. Serum prostate-specific antigen in a community-based population of healthy men, establishment of age-specific reference ranges
18. Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma
19. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen